Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models-Reference-Cited by-同舟云学术

Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models

Published:2019-09 Issue: Volume:138 Page:45-51
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Thor M.,Deasy Jo^ORCID,Iyer A.,Bendau E.,Fontanella A.,Apte A.,Yorke E.^ORCID,Rimner A.^ORCID,Jackson A.

Funder

NIH

NCI Cancer Center

NCI

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference23 articles.

1. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

2. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group;Perez;Cancer,1980

3. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial;Chun;J Clin Oncol,2017

4. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach;Langendijk;Radiother Oncol,2013

5. Use of Veff and iso-NTCP in the implementation of dose escalation protocols;Ten Haken;Int J Radiat Oncol Biol Phys,1993

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of Radiation Pneumonitis in Patients with Stage 3 Non-Small-Cell Lung Cancer Receiving Consolidation Durvalumab after Chemoradiation;European Journal of Cancer Care;2024-04-27

2. An¹⁸F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non–Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy;Journal of Nuclear Medicine;2024-03-14

3. ROE (Radiotherapy Outcomes Estimator): An open-source tool for optimizing radiotherapy prescriptions;Computer Methods and Programs in Biomedicine;2023-12

4. External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy;Radiotherapy and Oncology;2023-09

5. Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients;Radiotherapy and Oncology;2023-06